CD73 is an GPI-anchored ecto-5′-nucleotidase that is involved in the rapid conversion of pro-inflammatory extracellular ATP (eATP), released from cancer cells due to metabolic or therapy-induced stress, to adenosine (ADO), one of the most potent immunosuppressive regulatory molecules. Here, ADO is linked to cancer.